InsiderTrades

Form 4 for FCN FTI CONSULTING, INC

Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0000887936-24-000026 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-03-04 2024-02-29+ FCN Gunby Steven Henry Pres, CEO, Dir M - OptEx $36.87 +6,708 308.9K +2% +$247.3K
DM 2024-03-04 2024-02-29+ FCN Gunby Steven Henry Pres, CEO, Dir S - Sale+OE $207.48 -6,708 309.4K -2% -$1.39M
DM 2024-03-04 2024-02-29+ FCN Gunby Steven Henry Pres, CEO, Dir M - OptEx $0.00 -6,708 190.1K -3% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-01 M A 3,592 $36.87 312,521 D — —
2 Common Common Stock 2024-03-01 S D 3,592 $205.06 305,813 D — — (F2) On March 1, 2024, Mr. Gunby sold an aggregate of 3,592 shares of FTI Consulting, Inc. common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $204.75 to $205.46. The Company maintains a record of the transactions and copies will be provided upon request.
3 Common Common Stock 2024-02-29 S D 3,116 $210.28 309,405 D — — (F1) On February 29, 2024, Mr. Gunby sold an aggregate of 3,116 shares of FTI Consulting, Inc. common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $210.25 to $210.38. The Company maintains a record of the transactions and copies will be provided upon request.
4 Common Common Stock 2024-02-29 M A 3,116 $36.87 308,929 D — —
5 Derivative Stock Option (right to buy) 2024-03-01 M D 3,592 $0.00 186,472 D $36.87 · — to 2025-03-01 3,592 Common Stock (F3) All options pursuant to these awards vested and became exercisable in full on March 1, 2018.
6 Derivative Stock Option (right to buy) 2024-02-29 M D 3,116 $0.00 190,064 D $36.87 · — to 2025-03-01 3,116 Common Stock (F3) All options pursuant to these awards vested and became exercisable in full on March 1, 2018.